Yet another prestigious hospital joins the ranks of those reporting Carbapenem resistant enterobacteriaceae (CRE) infections, linked to endoscopic retrograde cholangiopancreatography (ERCP) endoscopes. On March 4th, Cedars-Sinai Medical Center in Los Angeles discovered that four patients were infected with CRE, and 67 others may have been exposed. On the same day, Hartford (CT) Hospital announced that as many as 281 patients may have come into contact with a "tough strain" of E. coli over the past year, but denied that it was CRE.
Two matters keep coming up: The non-use of proven ethylene oxide sterilization, and the detached attitude of the GI-docs. Then there's the dumb idea of blaming the scopes and going back to older models, as if the earlier design did not also have contamination problems. More than that, just about everyone thinks that many more similar cases will emerge—and not just with ERCP scopes.
One wonders when the rest of the medical community will put pressure on the GI-docs to show some leadership. Read the complete article.